Neoadjuvant PD-1 Blockade in Resectable Lung CancerPatrick M. Forde, Drew M. Pardoll, Stephen C. Yang et al.|New England Journal of Medicine|2018Cited by 2.1k
Transcriptional programs of neoantigen-specific TIL in anti-PD-1-treated lung cancersJustina X. Caushi, Kellie N. Smith, Taha Merghoub et al.|Nature|2021Cited by 546
Abstract 1126: CLSP-1025, a first-in-class precision T cell engager for the treatment of p53 mutant cancersMichael F. Maloney, Kristen McEachern, Justina X. Caushi et al.|Cancer Research|2025Cited by 0